Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,165 | 569 | 99.9% |
| Education | $13.63 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,559 | 114 | $0 (2024) |
| Merz North America, Inc. | $1,356 | 11 | $0 (2023) |
| Novo Nordisk Inc | $1,055 | 64 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $861.80 | 44 | $0 (2024) |
| Allergan, Inc. | $749.95 | 22 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $653.03 | 16 | $0 (2022) |
| Medtronic, Inc. | $561.33 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $408.29 | 21 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $375.96 | 4 | $0 (2023) |
| Amgen Inc. | $338.86 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,121 | 138 | ABBVIE INC. ($857.05) |
| 2023 | $3,706 | 125 | ABBVIE INC. ($1,202) |
| 2022 | $3,681 | 122 | ABBVIE INC. ($1,514) |
| 2021 | $2,788 | 55 | AbbVie Inc. ($1,986) |
| 2020 | $528.69 | 9 | Allergan, Inc. ($388.34) |
| 2019 | $377.55 | 9 | Allergan Inc. ($252.70) |
| 2018 | $1,335 | 94 | AstraZeneca Pharmaceuticals LP ($213.90) |
| 2017 | $641.45 | 19 | SANOFI-AVENTIS U.S. LLC ($389.51) |
All Payment Transactions
571 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Obesity | ||||||
| 12/16/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Durable Pump | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes | ||||||
| 12/07/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $54.38 | General |
| Category: Durable Pump | ||||||
| 12/05/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ORTHOPEDICS | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: PAIN | ||||||
| 11/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Diabetes Care | ||||||
| 11/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Biological | ||||||
| 11/04/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: Durable Pump | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.80 | General |
| 10/25/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Education | In-kind items and services | $8.90 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $15.14 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 10/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,696 | 2,822 | $387,655 | $120,261 |
| 2022 | 29 | 1,949 | 3,429 | $530,038 | $165,873 |
| 2021 | 35 | 2,439 | 4,975 | $584,075 | $201,459 |
| 2020 | 41 | 2,588 | 5,232 | $379,843 | $219,048 |
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 368 | 1,331 | $232,925 | $63,766 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 119 | 122 | $46,420 | $12,742 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 140 | 140 | $21,700 | $8,479 | 39.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 235 | 235 | $7,050 | $4,893 | 69.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 112 | 112 | $3,495 | $3,307 | 94.6% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 20 | 20 | $3,000 | $2,570 | 85.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 17 | $7,104 | $2,520 | 35.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 54 | 62 | $9,300 | $2,514 | 27.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 33 | 33 | $3,300 | $2,502 | 75.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 197 | 214 | $16,050 | $2,017 | 12.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 37 | $5,125 | $1,994 | 38.9% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 36 | 36 | $7,200 | $1,586 | 22.0% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 25 | 25 | $3,000 | $1,491 | 49.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $1,925 | $1,439 | 74.7% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 54 | 54 | $2,700 | $1,105 | 40.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 27 | 30 | $3,000 | $1,039 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $2,755 | $1,027 | 37.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 43 | 89 | $3,115 | $992.41 | 31.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 20 | 20 | $1,500 | $905.80 | 60.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 22 | 48 | $1,440 | $778.56 | 54.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 25 | 25 | $750.00 | $735.00 | 98.0% |
| 92552 | Test for hearing various pitches using earphone | Office | 2023 | 19 | 19 | $950.00 | $556.94 | 58.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 13 | $845.00 | $457.01 | 54.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $385.00 | $373.67 | 97.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 13 | 13 | $715.00 | $210.60 | 29.5% |
About Dr. Walid Elkhalili, MD
Dr. Walid Elkhalili, MD is a Internal Medicine healthcare provider based in Fair Lawn, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1205186756.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walid Elkhalili, MD has received a total of $16,179 in payments from pharmaceutical and medical device companies, with $3,121 received in 2024. These payments were reported across 571 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($16,165).
As a Medicare-enrolled provider, Elkhalili has provided services to 8,672 Medicare beneficiaries, totaling 16,458 services with total Medicare billing of $706,641. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Fair Lawn, NJ
- Active Since 09/12/2012
- Last Updated 02/03/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205186756
Products in Payments
- VRAYLAR (Drug) $3,802
- UBRELVY (Drug) $1,488
- Xeomin (Biological) $1,356
- FARXIGA (Drug) $653.70
- Ozempic (Drug) $498.48
- MINIMED 780G (Device) $497.15
- NURTEC ODT (Drug) $464.60
- TOUJEO (Drug) $449.15
- Linzess (Drug) $375.96
- XARELTO (Drug) $298.89
- XIFAXAN (Drug) $279.88
- CREON (Drug) $243.03
- Repatha (Biological) $209.83
- TRELEGY ELLIPTA (Drug) $200.48
- Rybelsus (Drug) $199.63
- SOLIQUA (Drug) $189.74
- JARDIANCE (Drug) $182.34
- LINZESS (Drug) $167.51
- Vascepa (Drug) $166.48
- BOTOX (Biological) $144.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fair Lawn
Joshua Balog, M.d, M.D
Internal Medicine — Payments: $17,629
Dr. Nina Safa, Md, MD
Internal Medicine — Payments: $10,848
Mira Upadhyaya, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $9,548
Dr. Mark Reyn, Md, MD
Internal Medicine — Payments: $8,475
Dr. Basel Batarseh, Md, MD
Internal Medicine — Payments: $7,812
Nina Logvinenko, M.d, M.D
Internal Medicine — Payments: $7,043